Hancock Whitney Corp Sorrento Therapeutics, Inc. Transaction History

Hancock Whitney Corp

  • $2.88 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021
SELL
$7.41 - $10.99 $926,250 - $1.37 Million
-125,000 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$7.03 - $16.51 $2,685 - $6,306
-382 Reduced 0.3%
125,000 $1.03 Million
Q4 2020

Feb 09, 2021
SELL
$5.76 - $11.95 $43,752 - $90,772
-7,596 Reduced 5.71%
125,382 $856,000
Q3 2020

Nov 05, 2020
SELL
$6.17 - $18.82 $229,906 - $701,270
-37,262 Reduced 21.89%
132,978 $1.48 Million
Q2 2020

Jul 30, 2020
BUY
$1.73 - $6.76 $294,515 - $1.15 Million
170,240 New
170,240 $1.07 Million

Others Institutions Holding SRNE

# of Institutions
15
Shares Held
5.51M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email